AI Insight
This is a correction notice for a previously published research article that examined methods for systematically evaluating clinical trials that were terminated early and registered in ClinicalTrials.gov. The original study analyzed a cohort of clinical trials from Germany and California to develop scalable approaches for assessing why trials were discontinued. The correction addresses errors or omissions in the original publication.
Why it matters
Understanding why clinical trials terminate prematurely is important for improving trial design, protecting research participants, and ensuring efficient use of research resources. Scalable assessment methods could help regulatory bodies and research institutions better monitor and learn from discontinued trials.
Understand the Science
by Samruddhi Suresh Yerunkar, Benjamin Gregory Carlisle, Delwen L. Franzen, Maia Salholz-Hillel, Daniel Strech, Susanne Gabriele Schorr